MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 215 filers reported holding MYRIAD GENETICS INC in Q3 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $166,126 | -30.8% | 10,357 | 0.0% | 0.04% | -30.2% |
Q2 2023 | $240,075 | -0.2% | 10,357 | 0.0% | 0.06% | -4.5% |
Q1 2023 | $240,593 | +60.1% | 10,357 | 0.0% | 0.07% | +53.5% |
Q4 2022 | $150,280 | -24.1% | 10,357 | 0.0% | 0.04% | -29.5% |
Q3 2022 | $198,000 | +5.3% | 10,357 | 0.0% | 0.06% | -3.2% |
Q2 2022 | $188,000 | -28.0% | 10,357 | 0.0% | 0.06% | -19.2% |
Q1 2022 | $261,000 | -8.7% | 10,357 | 0.0% | 0.08% | -8.2% |
Q4 2021 | $286,000 | -14.4% | 10,357 | 0.0% | 0.08% | -18.3% |
Q3 2021 | $334,000 | +5.4% | 10,357 | 0.0% | 0.10% | +4.0% |
Q2 2021 | $317,000 | +0.6% | 10,357 | 0.0% | 0.10% | -5.7% |
Q1 2021 | $315,000 | -5.4% | 10,357 | -38.6% | 0.11% | -11.7% |
Q4 2020 | $333,000 | +51.4% | 16,857 | 0.0% | 0.12% | +41.2% |
Q3 2020 | $220,000 | +15.2% | 16,857 | 0.0% | 0.08% | +6.2% |
Q2 2020 | $191,000 | -20.7% | 16,857 | 0.0% | 0.08% | -29.8% |
Q1 2020 | $241,000 | -25.4% | 16,857 | +42.2% | 0.11% | -16.8% |
Q4 2019 | $323,000 | – | 11,857 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
RK Capital | 384,900 | $16,612,000 | 2.90% |
Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |